No Association between Gastrointestinal Rebleeding and DOAC Therapy Resumption: A Systematic Review and Meta-Analysis.
Biomedicines（2023）
摘要
DOAC resumption after a GIB episode may not elevate the risk of rebleeding. However, the need for high-quality randomized clinical trials is crucial.
更多查看译文
关键词
efficacy,gastrointestinal hemorrhage,non-vitamin K antagonist oral anticoagulant (NOAC),safety,therapy resumption
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要